{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T06:50:26Z","timestamp":1787899826437,"version":"build-2784847793"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,4,30]],"date-time":"2009-04-30T00:00:00Z","timestamp":1241049600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Daptomycin, a lipopeptide antibiotic, could be an alternative to vancomycin for treatment of pneumococcal meningitis. We determined the activity of daptomycin versus vancomycin, with dexamethasone as an adjuvant, in a murine model of pneumococcal meningitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Ninety-six 25\u201330 gram mice were inoculated intracisternally with serotype 3 <jats:italic>Streptococcus pneumoniae<\/jats:italic> modified by the integration of a luminescent <jats:italic>lux<\/jats:italic> operon. All mice were treated with either dexamethasone 1 mg\/kg intraperitoneally every 6 hours alone or in combination with either vancomycin or daptomycin, also administered intraperitoneally. Serum antimicrobial concentrations were selected to approximate those achieved in humans. Following treatment, bioluminescence and cerebrospinal fluid (CSF) bacterial concentrations were determined. Caspase-3 staining was used to assess apoptosis on brain histopathology.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Sixteen hours post intracisternal inoculation, bacterial titers in CSF were 6.8 log<jats:sub>10<\/jats:sub> cfu\/ml. Amongst the animals given no antibiotic, vancomycin 50 mg\/kg at 16 and 20 hours or daptomycin 25 mg\/kg at 16 hours, CSF titers were 7.6, 3.4, and 3.9 log<jats:sub>10<\/jats:sub> cfu\/ml, respectively, at 24 hours post infection (p-value, &lt; 0.001 for both vancomycin or daptomycin versus no antibiotic); there was no significant difference in bactericidal activity between the vancomycin and daptomycin groups (p-value, 0.18). CSF bioluminescence correlated with bacterial titer (Pearson regression coefficient, 0.75). The amount of apoptosis of brain parenchymal cells was equivalent among treatment groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Daptomycin or vancomycin, when given in combination with dexamethasone, is active in the treatment of experimental pneumococcal meningitis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2334-9-50","type":"journal-article","created":{"date-parts":[[2009,4,30]],"date-time":"2009-04-30T18:16:19Z","timestamp":1241115379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Daptomycin in experimental murine pneumococcal meningitis"],"prefix":"10.1186","volume":"9","author":[{"given":"Barry B","family":"Mook-Kanamori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S","family":"Rouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheol-In","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diederik","family":"van de Beek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M","family":"Steckelberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,4,30]]},"reference":[{"key":"815_CR1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1056\/NEJMra052116","volume":"354","author":"D van de Beek","year":"2006","unstructured":"Beek van de D, de Gans J, Tunkel AR, et al: Community-acquired bacterial meningitis in adults. N Engl J Med. 2006, 354: 44-53. 10.1056\/NEJMra052116.","journal-title":"N Engl J Med"},{"key":"815_CR2","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1086\/383472","volume":"38","author":"CF Carpenter","year":"2004","unstructured":"Carpenter CF, Chambers HF: Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens. Clin Infect Dis. 2004, 38: 994-1000. 10.1086\/383472.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"815_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1469-0691.2006.01342.x","volume":"12","author":"MJ Rybak","year":"2006","unstructured":"Rybak MJ: The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria. Clin Microbiol Infect. 2006, 12 (Suppl 1): 24-32. 10.1111\/j.1469-0691.2006.01342.x.","journal-title":"Clin Microbiol Infect"},{"key":"815_CR4","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1128\/IAI.69.5.3350-3358.2001","volume":"69","author":"KP Francis","year":"2001","unstructured":"Francis KP, Yu J, Bellinger-Kawahara C, et al: Visualizing pneumococcal infections in the lungs of live mice using bioluminescent Streptococcus pneumoniae transformed with a novel gram-positive lux transposon. Infect Immun. 2001, 69: 3350-8. 10.1128\/IAI.69.5.3350-3358.2001.","journal-title":"Infect Immun"},{"key":"815_CR5","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1056\/NEJMoa040845","volume":"351","author":"D van de Beek","year":"2004","unstructured":"Beek van de D, de Gans J, Spanjaard L, et al: Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004, 351: 1849-59. 10.1056\/NEJMoa040845.","journal-title":"N Engl J Med"},{"key":"815_CR6","first-page":"M07-A7","volume-title":"Wayne","author":"Clinical and Laboratory Standards Institute","year":"2006","unstructured":"Clinical and Laboratory Standards Institute: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. Wayne. 2006, M07-A7-"},{"key":"815_CR7","first-page":"2731","volume-title":"Bacterial Tests, Laboratory Procedures in Clinical Microbiology","author":"JP Anhalt","year":"1985","unstructured":"Anhalt JP, Washington JA: Bacterial Tests, Laboratory Procedures in Clinical Microbiology. 1985, Springer Verlag, New York, NY, 2731-745. 2","edition":"2"},{"key":"815_CR8","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.1128\/AAC.48.10.3928-3933.2004","volume":"48","author":"P Cottagnoud","year":"2004","unstructured":"Cottagnoud P, Pfister M, Acosta F, et al: Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis. Antimicrob Agents Chemother. 2004, 48: 3928-33. 10.1128\/AAC.48.10.3928-3933.2004.","journal-title":"Antimicrob Agents Chemother"},{"key":"815_CR9","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1093\/jac\/dkl007","volume":"57","author":"P Gerber","year":"2006","unstructured":"Gerber P, Stucki A, Acosta F, et al: Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis. J Antimicrob Chemother. 2006, 57: 720-3. 10.1093\/jac\/dkl007.","journal-title":"J Antimicrob Chemother"},{"key":"815_CR10","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1128\/AAC.01000-06","volume":"51","author":"A Stucki","year":"2007","unstructured":"Stucki A, Cottagnoud M, Winkelmann V, et al: Daptomycin produces an enhanced bactericidal activity compared to ceftriaxone, measured by [3H]choline release in the cerebrospinal fluid, in experimental meningitis due to a penicillin-resistant pneumococcal strain without lysing its cell wall. Antimicrob Agents Chemother. 2007, 51: 2249-52. 10.1128\/AAC.01000-06.","journal-title":"Antimicrob Agents Chemother"},{"key":"815_CR11","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1128\/AAC.01014-06","volume":"51","author":"D Grandgirard","year":"2007","unstructured":"Grandgirard D, Schurch C, Cottagnoud P, et al: Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis. Antimicrob Agents Chemother. 2007, 51: 2173-8. 10.1128\/AAC.01014-06.","journal-title":"Antimicrob Agents Chemother"},{"key":"815_CR12","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1128\/AAC.38.6.1320","volume":"38","author":"MM Paris","year":"1994","unstructured":"Paris MM, Hickey SM, Uscher MI, et al: Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother. 1994, 38: 1320-4.","journal-title":"Antimicrob Agents Chemother"},{"key":"815_CR13","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1128\/AAC.39.9.2158","volume":"39","author":"C Cabellos","year":"1995","unstructured":"Cabellos C, Martinez-Lacasa J, Martos A, et al: Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis. Antimicrob Agents Chemother. 1995, 39: 2158-60.","journal-title":"Antimicrob Agents Chemother"},{"key":"815_CR14","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1086\/420818","volume":"38","author":"RD Arbeit","year":"2004","unstructured":"Arbeit RD, Maki D, Tally FP, et al: The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. Clin Infect Dis. 2004, 38: 1673-81. 10.1086\/420818.","journal-title":"Clin Infect Dis"},{"key":"815_CR15","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1086\/590257","volume":"47","author":"DH Lee","year":"2008","unstructured":"Lee DH, Palermo B, Chowdhury M: Successful treatment of methicillin-resistant Staphylococcus aureus meningitis with daptomycin. Clin Infect Dis. 2008, 47: 588-90. 10.1086\/590257.","journal-title":"Clin Infect Dis"},{"key":"815_CR16","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1128\/AAC.01559-05","volume":"50","author":"BK English","year":"2006","unstructured":"English BK, Maryniw EM, Talati AJ, et al: Diminished macrophage inflammatory response to Staphylococcus aureus isolates exposed to daptomycin versus vancomycin or oxacillin. Antimicrob Agents Chemother. 2006, 50: 2225-7. 10.1128\/AAC.01559-05.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-9-50.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-9-50\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-9-50","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-9-50.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T07:34:10Z","timestamp":1630481650000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-9-50"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,30]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["815"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-9-50","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,30]]},"assertion":[{"value":"16 January 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"50"}}